08 Sep Trial participants are heroes, let’s treat them that way
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
Being a clinical trial participant, especially in an interventional trial, is a sacrifice of time and body and represents a true commitment on the part of the patient....
Restrictive eligibility criteria has been a concern for many oncology researchers, who believe these trials should reflect a broader real-world population....
The UW School of Medicine and Public Health's Dr. Sterling Johnson recently joined Wisconsin Public Radio to discuss the Wisconsin Registry for Alzheimer's Prevention (WRAP) study at the University of Wisconsin-Madison....
The results of Eli Lilly's donanemab trial have lit a fire to Alzheimer's disease research but what else is on the horizon?...
Dr. Jill Biden participated in a listening session at the Foundation for Black Women’s Wellness on Madison’s West Side where she and U.S. Sen. Tammy Baldwin spoke on a panel with many of Madison and Milwaukee’s community health leaders highlighting the importance of early detection and...
Health-related discoveries in people can lead to better medical care for dogs. Likewise, studies of dog biology can lead to better understanding and treatments for people....
Wisconsin Senator Tammy Baldwin recently visited the Wisconsin Institutes for Medical Research at UW–Madison, highlighting the university’s experience and expertise as a collaborative powerhouse in bioscience and technology....
Just one dose of psilocybin significantly improved depression symptoms and functional disability in patients with major depressive disorder (MDD), a randomized trial found....
Are faster drug approvals by the FDA hurting the public's overall perception of clinical research?...
Commenters on the FDA's guidance on clinical investigations and drug development programs for psychedelic drugs raised concerns about decoupling drug administration from psychotherapy support, the proposed credentials for lead safety monitors and the agency’s characterization of the abuse potential of psychedelic drugs....